Business
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.
Sehat Kahani is now exploring predictive AI in telehealth.
Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.
The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.
The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.
Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.
Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.